ZENCORE NEWS & EVENTS

News & Events News & Events

Funding Update | Zencore Biologics Announced The Completion of 100 Million RMB ($14.74 Million) Series C+ Funding

2022-08-19 Zencore News

Zencore Biologics announced the completion of 100 million RMB ($14.74 Million) Series C+ funding.

More NewsMore News
Breaking News | Zencore Biologics Successfully Obtains the “Drug Production License,” Reaching an Important Milestone in Its Growth
2025-01-16

Breaking News | Zencore Biologics Successfully Obtains the “Drug Production License,” Reaching an Important Milestone in Its Growth

View details →
Congratulations | Novotel Biotech Approved to Conduct Phase I Clinical Trial of Recombinant Human Hyaluronidase Injection
2024-12-31

Congratulations | Novotel Biotech Approved to Conduct Phase I Clinical Trial of Recombinant Human Hyaluronidase Injection

View details →
Zencore's "Hyaluronidase" Pharmaceutical Excipient Registered with NMPA
2024-12-22

Zencore's "Hyaluronidase" Pharmaceutical Excipient Registered with NMPA

View details →